Cargando…

Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment

INTRODUCTION: Opioids are needed for postoperative pain in spine surgery patients, but opioid-induced constipation is a harmful adverse event. The aim of this clinical trial was to compare the use of a controlled-release oxycodone-naloxone combination product with oxycodone controlled-release tablet...

Descripción completa

Detalles Bibliográficos
Autores principales: Kokki, Merja, Kuronen, Moona, Naaranlahti, Toivo, Nyyssönen, Timo, Pikkarainen, Ira, Savolainen, Sakari, Kokki, Hannu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216064/
https://www.ncbi.nlm.nih.gov/pubmed/27921252
http://dx.doi.org/10.1007/s12325-016-0456-9
_version_ 1782491855774023680
author Kokki, Merja
Kuronen, Moona
Naaranlahti, Toivo
Nyyssönen, Timo
Pikkarainen, Ira
Savolainen, Sakari
Kokki, Hannu
author_facet Kokki, Merja
Kuronen, Moona
Naaranlahti, Toivo
Nyyssönen, Timo
Pikkarainen, Ira
Savolainen, Sakari
Kokki, Hannu
author_sort Kokki, Merja
collection PubMed
description INTRODUCTION: Opioids are needed for postoperative pain in spine surgery patients, but opioid-induced constipation is a harmful adverse event. The aim of this clinical trial was to compare the use of a controlled-release oxycodone-naloxone combination product with oxycodone controlled-release tablets in these patients. The main outcome measure was the prevalence of constipation at 7 days postoperatively assessed with a Bowel Function Index questionnaire. A follow-up assessment at 21 days after surgery was also included. METHODS: A total of 180 patients undergoing spine surgery, 91 having preoperative opioids in use and 89 opioid-naïve, were randomized to receive twice-daily oxycodone 10 mg or oxycodone-naloxone 10/5 mg controlled-release tablets for the first 7 postoperative days. Patients were followed-up for 21 days after surgery. RESULTS: At baseline, prevalence of constipation was common both in the opioid-naïve—25/87 (29%) and on-opioid groups 43/90 (48%) (P = 0.009). This increased at 7 days postoperatively with no difference between the groups, 54/89 with oxycodone and 54/88 with oxycodone-naloxone had constipation. At 21 days, constipation was less than in the baseline in both groups, in the opioid-naïve group the prevalence of constipation was 3/43 (7%) in patients with oxycodone-naloxone compared to 9/44 (21%) with oxycodone (effect size 0.68; P = 0.068). Both study compounds provided similar pain relief and were well tolerated. CONCLUSION: In patients presented for back surgery, the prevalence of constipation was significantly higher than that in the community. In opioid-naïve subjects, oxycodone-naloxone was beneficial concerning constipation; but this was not distinguishable in subjects with chronic opioid use. The analgesic efficacy of oxycodone and oxycodone-naloxone was similar. Trial registration: European Clinical Trials Database (EudraCT no. 2012-001816-42) and ClinicalTrials.gov database (Identifier: NCT02573922).
format Online
Article
Text
id pubmed-5216064
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-52160642017-01-18 Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment Kokki, Merja Kuronen, Moona Naaranlahti, Toivo Nyyssönen, Timo Pikkarainen, Ira Savolainen, Sakari Kokki, Hannu Adv Ther Original Research INTRODUCTION: Opioids are needed for postoperative pain in spine surgery patients, but opioid-induced constipation is a harmful adverse event. The aim of this clinical trial was to compare the use of a controlled-release oxycodone-naloxone combination product with oxycodone controlled-release tablets in these patients. The main outcome measure was the prevalence of constipation at 7 days postoperatively assessed with a Bowel Function Index questionnaire. A follow-up assessment at 21 days after surgery was also included. METHODS: A total of 180 patients undergoing spine surgery, 91 having preoperative opioids in use and 89 opioid-naïve, were randomized to receive twice-daily oxycodone 10 mg or oxycodone-naloxone 10/5 mg controlled-release tablets for the first 7 postoperative days. Patients were followed-up for 21 days after surgery. RESULTS: At baseline, prevalence of constipation was common both in the opioid-naïve—25/87 (29%) and on-opioid groups 43/90 (48%) (P = 0.009). This increased at 7 days postoperatively with no difference between the groups, 54/89 with oxycodone and 54/88 with oxycodone-naloxone had constipation. At 21 days, constipation was less than in the baseline in both groups, in the opioid-naïve group the prevalence of constipation was 3/43 (7%) in patients with oxycodone-naloxone compared to 9/44 (21%) with oxycodone (effect size 0.68; P = 0.068). Both study compounds provided similar pain relief and were well tolerated. CONCLUSION: In patients presented for back surgery, the prevalence of constipation was significantly higher than that in the community. In opioid-naïve subjects, oxycodone-naloxone was beneficial concerning constipation; but this was not distinguishable in subjects with chronic opioid use. The analgesic efficacy of oxycodone and oxycodone-naloxone was similar. Trial registration: European Clinical Trials Database (EudraCT no. 2012-001816-42) and ClinicalTrials.gov database (Identifier: NCT02573922). Springer Healthcare 2016-12-05 2017 /pmc/articles/PMC5216064/ /pubmed/27921252 http://dx.doi.org/10.1007/s12325-016-0456-9 Text en © The Author(s) 2016 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research
Kokki, Merja
Kuronen, Moona
Naaranlahti, Toivo
Nyyssönen, Timo
Pikkarainen, Ira
Savolainen, Sakari
Kokki, Hannu
Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment
title Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment
title_full Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment
title_fullStr Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment
title_full_unstemmed Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment
title_short Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment
title_sort opioid-induced bowel dysfunction in patients undergoing spine surgery: comparison of oxycodone and oxycodone-naloxone treatment
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216064/
https://www.ncbi.nlm.nih.gov/pubmed/27921252
http://dx.doi.org/10.1007/s12325-016-0456-9
work_keys_str_mv AT kokkimerja opioidinducedboweldysfunctioninpatientsundergoingspinesurgerycomparisonofoxycodoneandoxycodonenaloxonetreatment
AT kuronenmoona opioidinducedboweldysfunctioninpatientsundergoingspinesurgerycomparisonofoxycodoneandoxycodonenaloxonetreatment
AT naaranlahtitoivo opioidinducedboweldysfunctioninpatientsundergoingspinesurgerycomparisonofoxycodoneandoxycodonenaloxonetreatment
AT nyyssonentimo opioidinducedboweldysfunctioninpatientsundergoingspinesurgerycomparisonofoxycodoneandoxycodonenaloxonetreatment
AT pikkarainenira opioidinducedboweldysfunctioninpatientsundergoingspinesurgerycomparisonofoxycodoneandoxycodonenaloxonetreatment
AT savolainensakari opioidinducedboweldysfunctioninpatientsundergoingspinesurgerycomparisonofoxycodoneandoxycodonenaloxonetreatment
AT kokkihannu opioidinducedboweldysfunctioninpatientsundergoingspinesurgerycomparisonofoxycodoneandoxycodonenaloxonetreatment